Yale: Beyond GLP-1s - Combination Therapy, New Hormones Reshape Obesity Treatment
August 21, 2026
August 21, 2026
NEW HAVEN, Connecticut, Aug. 21 -- Yale University issued the following news:
* * *
Beyond GLP-1s: Combination Therapy, New Hormones Reshape Obesity Treatment
As GLP-1 medications transform obesity care, researchers are testing new hormone combinations aimed at improving weight loss, tolerability, and long-term outcomes.
By Carrie MacMillan
The first wave of blockbuster obesity medications, including semaglutide (Ozempic, Wegovy) . . .
* * *
Beyond GLP-1s: Combination Therapy, New Hormones Reshape Obesity Treatment
As GLP-1 medications transform obesity care, researchers are testing new hormone combinations aimed at improving weight loss, tolerability, and long-term outcomes.
By Carrie MacMillan
The first wave of blockbuster obesity medications, including semaglutide (Ozempic, Wegovy) . . .